Stephan et al, has found that the levels of serum GDF-15 in benign disease was higher than that in PCa 52, but increased serum GDF-15 concentration was strongly associated with advanced disease and progression of PCa 50. This evidence concerns the gene GDF15 and posterior cortical atrophy.